METARAMINOL TORBAY metaraminol (as tartrate) 5 mg/10 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

metaraminol torbay metaraminol (as tartrate) 5 mg/10 ml injection ampoule

clinect pty ltd - metaraminol tartrate, quantity: 9.5 mg (equivalent: metaraminol, qty 5 mg) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium metabisulfite - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. ,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

METARAMINOL TORBAY metaraminol (as tartrate)10 mg/1 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

metaraminol torbay metaraminol (as tartrate)10 mg/1 ml injection ampoule

clinect pty ltd - metaraminol tartrate, quantity: 19 mg (equivalent: metaraminol, qty 10 mg) - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; water for injections - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. ,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

METARAMINOL TORBAY metaraminol (as tartrate) 2.5 mg/5 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

metaraminol torbay metaraminol (as tartrate) 2.5 mg/5 ml injection ampoule

clinect pty ltd - metaraminol tartrate, quantity: 4.75 mg (equivalent: metaraminol, qty 2.5 mg) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium metabisulfite - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. ,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

METARAMINOL GH PHARMA metaraminol (as tartrate) 10mg/1mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

metaraminol gh pharma metaraminol (as tartrate) 10mg/1ml injection ampoule

global harvest pharmaceuticals pty ltd - metaraminol tartrate, quantity: 19 mg (equivalent: metaraminol, qty 10 mg) - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; water for injections - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

METARAMINOL JUNO metaraminol (as tartrate) 2.5 mg/5 mL solution for injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

metaraminol juno metaraminol (as tartrate) 2.5 mg/5 ml solution for injection pre-filled syringe

juno pharmaceuticals pty ltd - metaraminol tartrate, quantity: 4.744 mg (equivalent: metaraminol, qty 2.5 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; dilute hydrochloric acid - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia,adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. ,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

METARAMINOL JUNO metaraminol (as tartrate) 5 mg/10 mL solution for injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

metaraminol juno metaraminol (as tartrate) 5 mg/10 ml solution for injection pre-filled syringe

juno pharmaceuticals pty ltd - metaraminol tartrate, quantity: 9.488 mg (equivalent: metaraminol, qty 5 mg) - injection, solution - excipient ingredients: water for injections; dilute hydrochloric acid; sodium chloride - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia,adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. ,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

METARAMINOL PHEBRA metaraminol (as tartrate) 10 mg/1 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

metaraminol phebra metaraminol (as tartrate) 10 mg/1 ml injection vial

phebra pty ltd - metaraminol tartrate, quantity: 18.96 mg (equivalent: metaraminol, qty 10 mg) - injection - excipient ingredients: water for injections; sodium metabisulfite; sodium chloride; sodium hydroxide; tartaric acid - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

METARAMINOL GH PHARMA metaraminol (as tartrate) 5 mg/10 mL solution for injection, vial Australia - English - Department of Health (Therapeutic Goods Administration)

metaraminol gh pharma metaraminol (as tartrate) 5 mg/10 ml solution for injection, vial

global harvest pharmaceuticals pty ltd - metaraminol tartrate, quantity: 9.5 mg (equivalent: metaraminol, qty 5 mg) - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; water for injections - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

METARAMINOL GH PHARMA metaraminol (as tartrate) 3 mg/6 mL solution for injection, vial Australia - English - Department of Health (Therapeutic Goods Administration)

metaraminol gh pharma metaraminol (as tartrate) 3 mg/6 ml solution for injection, vial

global harvest pharmaceuticals pty ltd - metaraminol tartrate, quantity: 5.7 mg (equivalent: metaraminol, qty 3 mg) - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; water for injections - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia

Metaraminol ARX metaraminol (as tartrate) 5 mg/10 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

metaraminol arx metaraminol (as tartrate) 5 mg/10 ml solution for injection ampoule

arrotex pharmaceuticals pty ltd - metaraminol tartrate, quantity: 9.49 mg (equivalent: metaraminol, qty 5 mg) - injection, solution - excipient ingredients: water for injections; sodium metabisulfite; sodium chloride - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.